Z-0464-2022 Class II Terminated

Recalled by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) — Mounds View, MN

FDA device recall Z-0464-2022 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Nov 19, 2021 and is designated Class II. Reason for recall: There have been reports of stent migration. The recall status is terminated (terminated Aug 16, 2024). Affected quantity: 21,653 devices.

Recall details

Product Type
Devices
Report Date
Jan 12, 2022
Initiation Date
Nov 19, 2021
Termination Date
Aug 16, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
21,653 devices

Product description

Instructions for Use for all model numbers of the Medtronic Abre Venous Self-Expanding Stent System.

Reason for recall

There have been reports of stent migration.

Distribution pattern

Distribution was nationwide. There was also military/government distribution. Foreign distribution was made to Argentina, Australia, Austria, Bahrain, Belgium, Botswana, Bulgaria, Canary Islands, Chile, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Guatemala, Hong Kong, India, Ireland, Israel, Italy, Jordan, Kenya, Lithuania, Malaysia, Republic of Moldova, Netherlands, New Zealand, Nicaragua, Norway, Oman, Peru, Poland, Portugal, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, and Viet Nam,

Code information

The IFU for all model numbers and serial numbers.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0464-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0464-2022. Report a data issue: hello@regdatalab.com.